On November 25, 2014, Dr. Bernhard Seifried, Senior Scientist and Engineer at Ceapro Inc., was awarded the Scientific Achievement and Innovation Award at the 15th Annual BioAlberta Awards Gala. This award is presented to an individual or a team who is responsible for a breakthrough innovation with commercial application. Dr. Seifried has co-invented, commercialized and scaled- up a novel platform processing technology called Pressurized Gas Expanded Liquid Technology or PGX which is used to purify, micronize, impregnate and functionalize biopolymers. This spraying process occurs under mild operating conditions of 40°C at 100 bar, without the use of capillary forces or agglomeration. PGX has several key advantages over conventional drying and purification technologies. PGX is ideally suited for processing challenging high-molecular weight water soluble bio-polymers and has the ability to make ultra-light, highly porous polymer structures, also known as aerogels with a huge specific surface area (>250 m2/gram) on a continuous basis - something that is not possible using todays conventional technologies. With PGX, drying, purification, decolorizing, and de-odorizing of fermented biomass is possible in a single process, while also extracting valuable antioxidants. This game-changing technology is suitable for a wide range of industries including functional food and cosmetic ingredients, drug delivery, hydrogels, absorbents, biomedical devices, wound healing/scaffolding and biocomposites.
Read more on PGX technology
About Ceapro Inc.
Ceapro Inc. is a Canadian biotechnology company involved in the development of proprietary extraction technology and the application of this technology to the production of extracts and “active ingredients” from oats and other renewable plant resources. Ceapro adds further value to its extracts by supporting their use in cosmeceutical, nutraceutical, and therapeutics products for humans and animals.
Nature’s vitality underlies all of Ceapro’s products and determines every aspect of its character. The company fosters the natural and renewable. Our aim over the past decade of research has always been to provide entirely “green” and innovative functional ingredients to both the manufacturers of personal care products and the developers of therapeutics for human and animal well-being.
They have a broad range of expertise in natural product chemistry, microbiology, biochemistry, immunology and process engineering. These skills merge in the fields of active ingredients, biopharmaceuticals and drug-delivery solutions.
Ceapro Inc. is a public company, trading on the TSXV (symbol: CZO).